Cargando…
sST2 Levels Show No Association with Helicobacter pylori Infection in Asymptomatic Patients: Implications for Biomarker Research
INTRODUCTION: Helicobacter pylori (H. pylori) is a prevalent stomach bacterium that can cause a range of clinical outcomes, including gastric cancer. In recent years, soluble suppression of tumorigenicity-2 (sST2) has gained attention as a biomarker associated with various diseases, such as gastric...
Autores principales: | Wernly, Sarah, Paar, Vera, Völkerer, Andreas, Semmler, Georg, Datz, Christian, Lichtenauer, Michael, Wernly, Bernhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352442/ https://www.ncbi.nlm.nih.gov/pubmed/37338618 http://dx.doi.org/10.1007/s10620-023-08005-0 |
Ejemplares similares
-
Helicobacter pylori and cardiovascular risk: Only a dead Helicobacter is a good Helicobacter?
por: Wernly, Sarah, et al.
Publicado: (2022) -
The Association between Helicobacter pylori and Colorectal Neoplasia
por: Wernly, Sarah, et al.
Publicado: (2022) -
Diverticulosis and cardiometabolic risk factors: a systematic literature review
por: Völkerer, Andreas, et al.
Publicado: (2023) -
Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease
por: Semmler, Georg, et al.
Publicado: (2023) -
Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related Mortality
por: Wernly, Sarah, et al.
Publicado: (2022)